Dr. Avron H. Lipschitz, MD

Dr. Lipschitz practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Dr. Lipschitz's NPI, 1336343102, was assigned on June 13, 2007. Dr. Lipschitz graduated from University of Cape Town Faculty of Medicine in 1999. Dr. Lipschitz holds Florida license ME108557.

Dr. Lipschitz's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Dr. Lipschitz's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. The medical group on file is Athena Plastic Surgery. Dmand AI also links Dr. Lipschitz to 2 more home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lipschitz practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Lipschitz's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Lipschitz is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Lipschitz is licensed in Florida.

Dmand AI lists breast reconstruction, breast surgery, cancerous skin growth removal, head wound and removal of damaged skin or skin graft among the conditions Dr. Lipschitz treats.

CMS data shows 2,240 Medicare services from Dr. Lipschitz across 15 procedure codes in 2024, for 167 Medicare patients. Medicare paid $2,167,321 for them. Every service was in an office.

CMS counts 167 Medicare patients who saw Dr. Lipschitz in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lipschitz's median patient age at 74, with 59% women.

In 2024, Dr. Lipschitz wrote 552 Medicare Part D claims for 176 patients. 97% of them were for generic drugs. CMS names the drug for 449 of them, across 11 drugs with 11 or more claims each, at $4,424 in total drug cost. In 2023, CMS named 261 claims across 9 drugs.

Dr. Lipschitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of melanoma (skin cancer) excision by Dr. Lipschitz, more than 83% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Lipschitz in 2010. The most frequent topics are Lipectomy, Lidocaine and Patient Satisfaction. Dr. Lipschitz has published most often in Plast Reconstr Surg. Dr. Lipschitz's most frequent co-authors are Rodney J. Rohrich, MD, Jeffrey Miller Kenkel, MD and Eric Alan Appelt, MD.

CMS Open Payments shows 380 general payments to Dr. Lipschitz from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Merz North America, Inc. paid the most, $20,725.

Dmand AI lists 9 awards for Dr. Lipschitz, most recently Florida Top Doc in 2024.

Dr. Lipschitz graduated from University of Cape Town Faculty of Medicine in 1999.

Dr. Lipschitz is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.